ACETO CORPORATION INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Aceto Corporation

NEW YORK, May 01, 2018 -- Wolf Haldenstein Adler Freeman & Herz LLP announces that an investor class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Aceto Corporation (NASDAQ:ACET) ("Aceto") on behalf of purchasers of Aceto common stock between August 25, 2017 and April 18, 2018, inclusive (the "Class Period").

Investors who have incurred losses in shares of Aceto Corporation are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action on our website, www.whafh.com.

If   you  have  incurred  losses  in  the  shares of  Aceto Corporation  and would like to assist with the litigation process as a lead plaintiff, you may, no later than June 25, 2018, request that the Court appoint you lead plaintiff of the proposed class. Please contact Wolf Haldenstein to learn more about your rights as an investor in Aceto Corporation.

Aceto is an international company engaged in the development, marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical  products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products.

The filed complaint alleges that, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that:

• Aceto failed to implement and enforce proper internal controls to identify the misapplication of cash;
   
• Aceto would incur large non-cash intangible asset impairment charges;
   
• Aceto lacked effective internal controls over financial reporting;
   
• Aceto's financial results for the fiscal year 2017 could not be relied upon;
   
• Aceto's fiscal 2018 financial guidance was overstated; and
   
• as a result of the foregoing, Aceto's public statements were materially false and misleading at all relevant times.

On April 18, 2018, Aceto issued a press release disclosing non-reliance on the previously issued 2018 fiscal year earnings guidance as well as the recording of non-cash intangible asset impairment charges, including goodwill, in the range of $230-$260 million.

Following this news, Aceto’s common stock declined $4.74, to close at, $2.66 on April 19, 2018, a decline of 64%.

Wolf Haldenstein Adler Freeman & Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.  The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego.  The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at [email protected], or visit our website at www.whafh.com.

Follow the firm and learn about newly filed cases on Twitter and Facebook.

Contact:

Wolf Haldenstein Adler Freeman & Herz LLP
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: [email protected], [email protected] or [email protected]
Tel: (800) 575-0735 or (212) 545-4774

Attorney Advertising. Prior results do not guarantee or predict a similar outcome.